Evidence map›Paper›PMID 32016628›Full record

ArticleInflammation2020

Deficiency of Phospholipase A

Hiroki Kishi, Kazuyuki Yamaguchi, Kazuhiro Watanabe, Kazuto Nakamura, Daisuke Fujioka, Kiyotaka Kugiyama

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Generation of aZoological research · 2026
    Article
  2. Updating Phospholipase ABiomolecules · 2020
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hiroki KishiDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kazuyuki YamaguchiDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kazuhiro WatanabeDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kazuto NakamuraDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Daisuke FujiokaDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan.
Kiyotaka KugiyamaDepartment of Internal Medicine II, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi, Japan. kugiyama@yamanashi.ac.jp.ORCID http://orcid.org/0000-0002-9138-4825
University of Yamanashi · JPJapan Agency for Medical Research and Development · JP

Funding

AMED-CREST JP17gm0710006Japan Society for the Promotion of Science B-22390158
6 · The paper itself

Abstract

Secretory phospholipase A

Indexed as

Disease ProgressionAnimalsMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMyocarditisNeutrophilsReceptors, Phospholipase A2T-LymphocytesReceptors, Phospholipase A2autoimmune myocarditiseicosanoidsphospholipase A2 receptorsecretory phospholipase A2Th17 cells

Identifiers

PMID32016628
OpenAlexW3004876152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.